SHFG
VRTX icon

S Harris Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

S Harris Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Sell
615
-1
-0.2% -$443 0.24% 75
2026
Q1 		$275K Buy
616
+155
+34% +$72.3K 0.25% 71
2025
Q4 		$209K Buy
+461
New +$199K 0.2% 82

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

S Harris Financial Group's VRTX Position: Q2 2026 in Review

S Harris Financial Group reduced its Vertex Pharmaceuticals (VRTX) stake by 0.16% in Q2 2026, selling an estimated $443 and leaving 615 shares worth $305K. The position accounts for 0.24% of the portfolio, ranked #75.

S Harris Financial Group first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,743 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • S Harris Financial Group held 615 shares of Vertex Pharmaceuticals worth $305K as of Q2 2026.
  • S Harris Financial Group sold 1 Vertex Pharmaceuticals share in Q2 2026, an estimated $443.
  • Vertex Pharmaceuticals made up 0.24% of S Harris Financial Group's portfolio in Q2 2026, its #75 holding.
  • S Harris Financial Group first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 1,743 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on S Harris Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.